APO Research

APO RESEARCH · REPORT

Megestrol

Selected research

Market Analysis & Forecast

Global Megestrol Market Analysis and Forecast 2026-2032

Market perspective

The global Megestrol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Megestrol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Megestrol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Megestrol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Megestrol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Megestrol include Abbott, Takeda, Sandoz, Novartis, Mylan, Pfizer, GSK, Mayne Pharma and Guccess, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Megestrol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Megestrol, also provides the sales of main regions and countries. Of the upcoming market potential for Megestrol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Megestrol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Megestrol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Megestrol sales, projected growth trends, production technology, application and end-user industry.

Megestrol Segment by Company

Abbott

Takeda

Sandoz

Novartis

Mylan

Pfizer

GSK

Mayne Pharma

Guccess

Bristol Myers Squibb

Abnova

Megestrol Segment by Type

Oral Suspension

Tablet

Injection

Others

Megestrol Segment by Application

Hospital

Clinic

Others

Megestrol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Megestrol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Megestrol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Megestrol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Megestrol sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Megestrol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Suspension Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Injection Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Megestrol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Megestrol Industry Trends Table 11. Megestrol Industry Drivers Table 12. Megestrol Industry Opportunities and Challenges Table 13. Megestrol Industry Restraints Table 14. Global Megestrol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Megestrol Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Megestrol Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Megestrol Revenue Market Share by Region (2021-2026) Table 18. Global Megestrol Revenue Market Share by Region (2027-2032) Table 19. Global Megestrol Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Megestrol Sales by Region (2021-2026) & (k units) Table 21. Global Megestrol Sales by Region (2027-2032) & (k units) Table 22. Global Megestrol Sales Market Share by Region (2021-2026) Table 23. Global Megestrol Sales Market Share by Region (2027-2032) Table 24. Global Megestrol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Megestrol Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Megestrol Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Megestrol Sales Market Share by Manufacturers (2021-2026) Table 28. Global Megestrol Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Megestrol Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Megestrol Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Megestrol Manufacturers, Product Type & Application Table 32. Global Megestrol Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Megestrol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Megestrol Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Megestrol Revenue Market Share by Type (2021-2026) Table 39. Global Megestrol Revenue Market Share by Type (2027-2032) Table 40. Global Megestrol Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Megestrol Sales by Type (2021-2026) & (k units) Table 42. Global Megestrol Sales by Type (2027-2032) & (k units) Table 43. Global Megestrol Sales Market Share by Type (2021-2026) Table 44. Global Megestrol Sales Market Share by Type (2027-2032) Table 45. Global Megestrol Price by Type (2021-2026) & (US$/unit) Table 46. Global Megestrol Price by Type (2027-2032) & (US$/unit) Table 47. Global Megestrol Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Megestrol Revenue Market Share by Application (2021-2026) Table 51. Global Megestrol Revenue Market Share by Application (2027-2032) Table 52. Global Megestrol Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Megestrol Sales by Application (2021-2026) & (k units) Table 54. Global Megestrol Sales by Application (2027-2032) & (k units) Table 55. Global Megestrol Sales Market Share by Application (2021-2026) Table 56. Global Megestrol Sales Market Share by Application (2027-2032) Table 57. Global Megestrol Price by Application (2021-2026) & (US$/unit) Table 58. Global Megestrol Price by Application (2027-2032) & (US$/unit) Table 59. Abbott Company Information Table 60. Abbott Business Overview Table 61. Abbott Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Abbott Megestrol Product Portfolio Table 63. Abbott Recent Development Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Takeda Megestrol Product Portfolio Table 68. Takeda Recent Development Table 69. Sandoz Company Information Table 70. Sandoz Business Overview Table 71. Sandoz Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sandoz Megestrol Product Portfolio Table 73. Sandoz Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Novartis Megestrol Product Portfolio Table 78. Novartis Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Mylan Megestrol Product Portfolio Table 83. Mylan Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Megestrol Product Portfolio Table 88. Pfizer Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GSK Megestrol Product Portfolio Table 93. GSK Recent Development Table 94. Mayne Pharma Company Information Table 95. Mayne Pharma Business Overview Table 96. Mayne Pharma Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Mayne Pharma Megestrol Product Portfolio Table 98. Mayne Pharma Recent Development Table 99. Guccess Company Information Table 100. Guccess Business Overview Table 101. Guccess Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Guccess Megestrol Product Portfolio Table 103. Guccess Recent Development Table 104. Bristol Myers Squibb Company Information Table 105. Bristol Myers Squibb Business Overview Table 106. Bristol Myers Squibb Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bristol Myers Squibb Megestrol Product Portfolio Table 108. Bristol Myers Squibb Recent Development Table 109. Abnova Company Information Table 110. Abnova Business Overview Table 111. Abnova Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Abnova Megestrol Product Portfolio Table 113. Abnova Recent Development Table 114. North America Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Megestrol Sales by Type (2021-2026) & (k units) Table 117. North America Megestrol Sales by Type (2027-2032) & (k units) Table 118. North America Megestrol Sales Price by Type (2021-2026) & (US$/unit) Table 119. North America Megestrol Sales Price by Type (2027-2032) & (US$/unit) Table 120. North America Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Megestrol Sales by Application (2021-2026) & (k units) Table 123. North America Megestrol Sales by Application (2027-2032) & (k units) Table 124. North America Megestrol Sales Price by Application (2021-2026) & (US$/unit) Table 125. North America Megestrol Sales Price by Application (2027-2032) & (US$/unit) Table 126. North America Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Megestrol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. North America Megestrol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. North America Megestrol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 130. North America Megestrol Sales by Country (2021-2026) & (k units) Table 131. North America Megestrol Sales by Country (2027-2032) & (k units) Table 132. North America Megestrol Sales Price by Country (2021-2026) & (US$/unit) Table 133. North America Megestrol Sales Price by Country (2027-2032) & (US$/unit) Table 134. United States Megestrol Revenue (2021-2032) & (US$ Million) Table 135. Canada Megestrol Revenue (2021-2032) & (US$ Million) Table 136. Mexico Megestrol Revenue (2021-2032) & (US$ Million) Table 137. Europe Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Megestrol Sales by Type (2021-2026) & (k units) Table 140. Europe Megestrol Sales by Type (2027-2032) & (k units) Table 141. Europe Megestrol Sales Price by Type (2021-2026) & (US$/unit) Table 142. Europe Megestrol Sales Price by Type (2027-2032) & (US$/unit) Table 143. Europe Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Megestrol Sales by Application (2021-2026) & (k units) Table 146. Europe Megestrol Sales by Application (2027-2032) & (k units) Table 147. Europe Megestrol Sales Price by Application (2021-2026) & (US$/unit) Table 148. Europe Megestrol Sales Price by Application (2027-2032) & (US$/unit) Table 149. Europe Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Megestrol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Megestrol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Megestrol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 153. Europe Megestrol Sales by Country (2021-2026) & (k units) Table 154. Europe Megestrol Sales by Country (2027-2032) & (k units) Table 155. Europe Megestrol Sales Price by Country (2021-2026) & (US$/unit) Table 156. Europe Megestrol Sales Price by Country (2027-2032) & (US$/unit) Table 157. Germany Megestrol Revenue (2021-2032) & (US$ Million) Table 158. France Megestrol Revenue (2021-2032) & (US$ Million) Table 159. U.K. Megestrol Revenue (2021-2032) & (US$ Million) Table 160. Italy Megestrol Revenue (2021-2032) & (US$ Million) Table 161. Russia Megestrol Revenue (2021-2032) & (US$ Million) Table 162. Spain Megestrol Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Megestrol Revenue (2021-2032) & (US$ Million) Table 164. Switzerland Megestrol Revenue (2021-2032) & (US$ Million) Table 165. Sweden Megestrol Revenue (2021-2032) & (US$ Million) Table 166. Poland Megestrol Revenue (2021-2032) & (US$ Million) Table 167. China Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 168. China Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 169. China Megestrol Sales by Type (2021-2026) & (k units) Table 170. China Megestrol Sales by Type (2027-2032) & (k units) Table 171. China Megestrol Sales Price by Type (2021-2026) & (US$/unit) Table 172. China Megestrol Sales Price by Type (2027-2032) & (US$/unit) Table 173. China Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 174. China Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 175. China Megestrol Sales by Application (2021-2026) & (k units) Table 176. China Megestrol Sales by Application (2027-2032) & (k units) Table 177. China Megestrol Sales Price by Application (2021-2026) & (US$/unit) Table 178. China Megestrol Sales Price by Application (2027-2032) & (US$/unit) Table 179. Asia Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 180. Asia Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 181. Asia Megestrol Sales by Type (2021-2026) & (k units) Table 182. Asia Megestrol Sales by Type (2027-2032) & (k units) Table 183. Asia Megestrol Sales Price by Type (2021-2026) & (US$/unit) Table 184. Asia Megestrol Sales Price by Type (2027-2032) & (US$/unit) Table 185. Asia Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 186. Asia Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Megestrol Sales by Application (2021-2026) & (k units) Table 188. Asia Megestrol Sales by Application (2027-2032) & (k units) Table 189. Asia Megestrol Sales Price by Application (2021-2026) & (US$/unit) Table 190. Asia Megestrol Sales Price by Application (2027-2032) & (US$/unit) Table 191. Asia Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Megestrol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Asia Megestrol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Asia Megestrol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. Asia Megestrol Sales by Country (2021-2026) & (k units) Table 196. Asia Megestrol Sales by Country (2027-2032) & (k units) Table 197. Asia Megestrol Sales Price by Country (2021-2026) & (US$/unit) Table 198. Asia Megestrol Sales Price by Country (2027-2032) & (US$/unit) Table 199. Japan Megestrol Revenue (2021-2032) & (US$ Million) Table 200. South Korea Megestrol Revenue (2021-2032) & (US$ Million) Table 201. India Megestrol Revenue (2021-2032) & (US$ Million) Table 202. Australia Megestrol Revenue (2021-2032) & (US$ Million) Table 203. Taiwan Megestrol Revenue (2021-2032) & (US$ Million) Table 204. Southeast Asia Megestrol Revenue (2021-2032) & (US$ Million) Table 205. SAMEA Megestrol Revenue by Type (2021-2026) & (US$ Million) Table 206. SAMEA Megestrol Revenue by Type (2027-2032) & (US$ Million) Table 207. SAMEA Megestrol Sales by Type (2021-2026) & (k units) Table 208. SAMEA Megestrol Sales by Type (2027-2032) & (k units) Table 209. SAMEA Megestrol Sales Price by Type (2021-2026) & (US$/unit) Table 210. SAMEA Megestrol Sales Price by Type (2027-2032) & (US$/unit) Table 211. SAMEA Megestrol Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Megestrol Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Megestrol Sales by Application (2021-2026) & (k units) Table 214. SAMEA Megestrol Sales by Application (2027-2032) & (k units) Table 215. SAMEA Megestrol Sales Price by Application (2021-2026) & (US$/unit) Table 216. SAMEA Megestrol Sales Price by Application (2027-2032) & (US$/unit) Table 217. SAMEA Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. SAMEA Megestrol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. SAMEA Megestrol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. SAMEA Megestrol Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 221. SAMEA Megestrol Sales by Country (2021-2026) & (k units) Table 222. SAMEA Megestrol Sales by Country (2027-2032) & (k units) Table 223. SAMEA Megestrol Sales Price by Country (2021-2026) & (US$/unit) Table 224. SAMEA Megestrol Sales Price by Country (2027-2032) & (US$/unit) Table 225. Brazil Megestrol Revenue (2021-2032) & (US$ Million) Table 226. Argentina Megestrol Revenue (2021-2032) & (US$ Million) Table 227. Chile Megestrol Revenue (2021-2032) & (US$ Million) Table 228. Colombia Megestrol Revenue (2021-2032) & (US$ Million) Table 229. Peru Megestrol Revenue (2021-2032) & (US$ Million) Table 230. Saudi Arabia Megestrol Revenue (2021-2032) & (US$ Million) Table 231. Israel Megestrol Revenue (2021-2032) & (US$ Million) Table 232. UAE Megestrol Revenue (2021-2032) & (US$ Million) Table 233. Turkey Megestrol Revenue (2021-2032) & (US$ Million) Table 234. Iran Megestrol Revenue (2021-2032) & (US$ Million) Table 235. Egypt Megestrol Revenue (2021-2032) & (US$ Million) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Megestrol Distributors List Table 239. Megestrol Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Megestrol Image Figure 2. Global Megestrol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Megestrol Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Suspension Image Figure 5. Tablet Image Figure 6. Injection Image Figure 7. Others Image Figure 8. Global Megestrol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Megestrol Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Megestrol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Megestrol Revenue (2021-2032) & (US$ Million) Figure 15. Global Megestrol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Megestrol Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Megestrol Revenue Market Share by Region (2021-2032) Figure 18. Global Megestrol Sales (2021-2032) & (k units) Figure 19. Global Megestrol Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Megestrol Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Megestrol Sales YoY (2021-2032) & (k units) Figure 22. Europe Megestrol Sales YoY (2021-2032) & (k units) Figure 23. China Megestrol Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Megestrol Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Megestrol Sales YoY (2021-2032) & (k units) Figure 26. Global Megestrol Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Megestrol Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Megestrol Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Megestrol Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Megestrol Revenue Market Share by Type (2021-2032) Figure 32. Global Megestrol Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Megestrol Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Megestrol Sales Market Share by Type (2021-2032) Figure 35. Global Megestrol Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Megestrol Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Megestrol Revenue Market Share by Application (2021-2032) Figure 38. Global Megestrol Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Megestrol Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Megestrol Sales Market Share by Application (2021-2032) Figure 41. North America Megestrol Revenue Share by Type (2021-2032) Figure 42. North America Megestrol Sales Share by Type (2021-2032) Figure 43. North America Megestrol Revenue Share by Application (2021-2032) Figure 44. North America Megestrol Sales Share by Application (2021-2032) Figure 45. North America Megestrol Revenue Share by Country (2021-2032) Figure 46. North America Megestrol Sales Share by Country (2021-2032) Figure 47. Europe Megestrol Revenue Share by Type (2021-2032) Figure 48. Europe Megestrol Sales Share by Type (2021-2032) Figure 49. Europe Megestrol Revenue Share by Application (2021-2032) Figure 50. Europe Megestrol Sales Share by Application (2021-2032) Figure 51. Europe Megestrol Revenue Share by Country (2021-2032) Figure 52. Europe Megestrol Sales Share by Country (2021-2032) Figure 53. China Megestrol Revenue Share by Type (2021-2032) Figure 54. China Megestrol Sales Share by Type (2021-2032) Figure 55. China Megestrol Revenue Share by Application (2021-2032) Figure 56. China Megestrol Sales Share by Application (2021-2032) Figure 57. Asia Megestrol Revenue Share by Type (2021-2032) Figure 58. Asia Megestrol Sales Share by Type (2021-2032) Figure 59. Asia Megestrol Revenue Share by Application (2021-2032) Figure 60. Asia Megestrol Sales Share by Application (2021-2032) Figure 61. Asia Megestrol Revenue Share by Country (2021-2032) Figure 62. Asia Megestrol Sales Share by Country (2021-2032) Figure 63. SAMEA Megestrol Revenue Share by Type (2021-2032) Figure 64. SAMEA Megestrol Sales Share by Type (2021-2032) Figure 65. SAMEA Megestrol Revenue Share by Application (2021-2032) Figure 66. SAMEA Megestrol Sales Share by Application (2021-2032) Figure 67. SAMEA Megestrol Revenue Share by Country (2021-2032) Figure 68. SAMEA Megestrol Sales Share by Country (2021-2032) Figure 69. Megestrol Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Megestrol Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Suspension
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Takeda
  • Sandoz
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Mayne Pharma
  • Guccess
  • Bristol Myers Squibb
  • Abnova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Megestrol Market by Type
  3. 1.2.1 Global Megestrol Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Suspension
  5. 1.2.3 Tablet
  6. 1.2.4 Injection
  7. 1.2.5 Others
  8. 1.3 Megestrol Market by Application
  9. 1.3.1 Global Megestrol Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Megestrol Market Dynamics
  1. 2.1 Megestrol Industry Trends
  2. 2.2 Megestrol Industry Drivers
  3. 2.3 Megestrol Industry Opportunities and Challenges
  4. 2.4 Megestrol Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Megestrol Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Megestrol Revenue by Region
  3. 3.2.1 Global Megestrol Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Megestrol Revenue by Region (2021-2026)
  5. 3.2.3 Global Megestrol Revenue by Region (2027-2032)
  6. 3.2.4 Global Megestrol Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Megestrol Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Megestrol Sales by Region
  9. 3.4.1 Global Megestrol Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Megestrol Sales by Region (2021-2026)
  11. 3.4.3 Global Megestrol Sales by Region (2027-2032)
  12. 3.4.4 Global Megestrol Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Megestrol Revenue by Manufacturers
  2. 4.1.1 Global Megestrol Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Megestrol Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Megestrol Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Megestrol Sales by Manufacturers
  6. 4.2.1 Global Megestrol Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Megestrol Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Megestrol Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Megestrol Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Megestrol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Megestrol Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Megestrol Manufacturers, Product Type & Application
  13. 4.7 Global Megestrol Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Megestrol Market CR5 and HHI
  16. 4.8.2 2025 Megestrol Tier 1, Tier 2, and Tier 3
5 Megestrol Market by Type
  1. 5.1 Global Megestrol Revenue by Type
  2. 5.1.1 Global Megestrol Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Megestrol Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Megestrol Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Megestrol Sales by Type
  6. 5.2.1 Global Megestrol Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Megestrol Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Megestrol Sales Market Share by Type (2021-2032)
  9. 5.3 Global Megestrol Price by Type
6 Megestrol Market by Application
  1. 6.1 Global Megestrol Revenue by Application
  2. 6.1.1 Global Megestrol Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Megestrol Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Megestrol Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Megestrol Sales by Application
  6. 6.2.1 Global Megestrol Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Megestrol Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Megestrol Sales Market Share by Application (2021-2032)
  9. 6.3 Global Megestrol Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Megestrol Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Megestrol Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Sandoz
  14. 7.3.1 Sandoz Company Information
  15. 7.3.2 Sandoz Business Overview
  16. 7.3.3 Sandoz Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sandoz Megestrol Product Portfolio
  18. 7.3.5 Sandoz Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Megestrol Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Megestrol Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Megestrol Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GSK
  38. 7.7.1 GSK Company Information
  39. 7.7.2 GSK Business Overview
  40. 7.7.3 GSK Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GSK Megestrol Product Portfolio
  42. 7.7.5 GSK Recent Developments
  43. 7.8 Mayne Pharma
  44. 7.8.1 Mayne Pharma Company Information
  45. 7.8.2 Mayne Pharma Business Overview
  46. 7.8.3 Mayne Pharma Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mayne Pharma Megestrol Product Portfolio
  48. 7.8.5 Mayne Pharma Recent Developments
  49. 7.9 Guccess
  50. 7.9.1 Guccess Company Information
  51. 7.9.2 Guccess Business Overview
  52. 7.9.3 Guccess Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Guccess Megestrol Product Portfolio
  54. 7.9.5 Guccess Recent Developments
  55. 7.10 Bristol Myers Squibb
  56. 7.10.1 Bristol Myers Squibb Company Information
  57. 7.10.2 Bristol Myers Squibb Business Overview
  58. 7.10.3 Bristol Myers Squibb Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bristol Myers Squibb Megestrol Product Portfolio
  60. 7.10.5 Bristol Myers Squibb Recent Developments
  61. 7.11 Abnova
  62. 7.11.1 Abnova Company Information
  63. 7.11.2 Abnova Business Overview
  64. 7.11.3 Abnova Megestrol Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Abnova Megestrol Product Portfolio
  66. 7.11.5 Abnova Recent Developments
8 North America
  1. 8.1 North America Megestrol Market Size by Type
  2. 8.1.1 North America Megestrol Revenue by Type (2021-2032)
  3. 8.1.2 North America Megestrol Sales by Type (2021-2032)
  4. 8.1.3 North America Megestrol Price by Type (2021-2032)
  5. 8.2 North America Megestrol Market Size by Application
  6. 8.2.1 North America Megestrol Revenue by Application (2021-2032)
  7. 8.2.2 North America Megestrol Sales by Application (2021-2032)
  8. 8.2.3 North America Megestrol Price by Application (2021-2032)
  9. 8.3 North America Megestrol Market Size by Country
  10. 8.3.1 North America Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Megestrol Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Megestrol Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Megestrol Market Size by Type
  2. 9.1.1 Europe Megestrol Revenue by Type (2021-2032)
  3. 9.1.2 Europe Megestrol Sales by Type (2021-2032)
  4. 9.1.3 Europe Megestrol Price by Type (2021-2032)
  5. 9.2 Europe Megestrol Market Size by Application
  6. 9.2.1 Europe Megestrol Revenue by Application (2021-2032)
  7. 9.2.2 Europe Megestrol Sales by Application (2021-2032)
  8. 9.2.3 Europe Megestrol Price by Application (2021-2032)
  9. 9.3 Europe Megestrol Market Size by Country
  10. 9.3.1 Europe Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Megestrol Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Megestrol Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Megestrol Market Size by Type
  2. 10.1.1 China Megestrol Revenue by Type (2021-2032)
  3. 10.1.2 China Megestrol Sales by Type (2021-2032)
  4. 10.1.3 China Megestrol Price by Type (2021-2032)
  5. 10.2 China Megestrol Market Size by Application
  6. 10.2.1 China Megestrol Revenue by Application (2021-2032)
  7. 10.2.2 China Megestrol Sales by Application (2021-2032)
  8. 10.2.3 China Megestrol Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Megestrol Market Size by Type
  2. 11.1.1 Asia Megestrol Revenue by Type (2021-2032)
  3. 11.1.2 Asia Megestrol Sales by Type (2021-2032)
  4. 11.1.3 Asia Megestrol Price by Type (2021-2032)
  5. 11.2 Asia Megestrol Market Size by Application
  6. 11.2.1 Asia Megestrol Revenue by Application (2021-2032)
  7. 11.2.2 Asia Megestrol Sales by Application (2021-2032)
  8. 11.2.3 Asia Megestrol Price by Application (2021-2032)
  9. 11.3 Asia Megestrol Market Size by Country
  10. 11.3.1 Asia Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Megestrol Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Megestrol Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Megestrol Market Size by Type
  2. 12.1.1 SAMEA Megestrol Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Megestrol Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Megestrol Price by Type (2021-2032)
  5. 12.2 SAMEA Megestrol Market Size by Application
  6. 12.2.1 SAMEA Megestrol Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Megestrol Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Megestrol Price by Application (2021-2032)
  9. 12.3 SAMEA Megestrol Market Size by Country
  10. 12.3.1 SAMEA Megestrol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Megestrol Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Megestrol Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Megestrol Value Chain Analysis
  2. 13.1.1 Megestrol Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Megestrol Production Mode & Process
  6. 13.2 Megestrol Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Megestrol Distributors
  9. 13.2.3 Megestrol Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research